Search

Search Results

• 

  In vitro effect of anti-β2 glycoprotein I antibodies on P-selectin expression, a marker of platelet activation

  A. Bontadi, A. Ruffatti, S Giannini, E. Falcinelli, M. Tonello, A. Hoxha, P. Gresele, L. Punzi

  35-39

  19-03-2012

  https://doi.org/10.4081/reumatismo.2012.35

  1720

  PDF: 693
• 

  The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus

  M. Taraborelli, M.G. Lazzaroni, N. Martinazzi, M. Fredi, I. Cavazzana, F. Franceschini, A. Tincani

  137-143

  16-12-2016

  https://doi.org/10.4081/reumatismo.2016.891

  2373

  PDF: 1396
• 

  Cryptogenic stroke and seronegative antiphospholipid syndrome: a case series of patients with positivity for “non-criteria” antiphospholipid antibodies

  S. Mancuso, M. De Michele, S. Truglia, A. Capozzi, L. Rapino, I. Berto, C. Alessandri, D. Toni, V. Manganelli, M. Sorice, F. Conti

  25-09-2024

  https://doi.org/10.4081/reumatismo.2024.1701

  1069

  PDF: 320
• 

  Fine specificity of anti-beta2glycoprotein I antibodies in systemic autoimmune diseases is mostly directed against domain 1

  C. Nalli, L. Andreoli, M. Motta, G.L. Norman, Z. Shums, W.L. Binder, M. Nuzzo, M. Frassi, A. Lojacono, A. Meini, V. Medeghini, T. Avcin, P.L. Meroni, A. Tincani

  91-96

  https://doi.org/10.4081/reumatismo.2011.91

  1409

  PDF: 793
• 

  Peripheral neuropathy in antiphospholipid syndrome: a systematic review

  Rafael Reis do Espírito Santos, Cezar Augusto Muniz Caldas, Jozélio Freire de Carvalho

  03-06-2025

  https://doi.org/10.4081/reumatismo.2025.1735

  2593

  PDF: 168

• Clinical value of antibodies to lysobisphosphatidic acid in patients with primary antiphospholipid sindrome

  S. Olivieri, A. Ruffatti, A. Bontadi, A. Cavazzana, E. Salvan, S. Cuffaro, S. Giunco, L. Punzi

  107-112

  https://doi.org/10.4081/reumatismo.2010.107

  1321

  PDF: 744
• 

  The use of tumor necrosis factor inhibitors during high-risk pregnancies in antiphospholipid syndrome: a clinical report of a patient with concomitant Takayasu arteritis and case-based review

  Liala Moschetti, Francesca Crisafulli, Francesca Regola, Rossana Orabona, Sofia Pitsigavdaki, Franco Franceschini, Laura Andreoli, Sonia Zatti, Angela Tincani

  29-07-2025

  https://doi.org/10.4081/reumatismo.2025.1835

  1179

  PDF: 93

• Sensibility and specificity for pregnancy morbidity of anti-b2-glycoprotein I antibodies in antiphospholipid syndrome

  M. Tonello, A. Ruffatti, M. Favaro, T. Del Ross, D. Zamboni, P. Grypiotis, A. Cavazzana, M. Ciprian, S. Todesco

  262-266

  https://doi.org/10.4081/reumatismo.2005.262

  1184

  PDF: 1076

• Subpopulations of anti-β2glycoprotein I antibodies with different pathogenic potential: fine specificity against the domains of β2glycoprotein I

  L. Andreoli, C. Nalli, M. Motta, G.L. Norman, W.L. Binder, M. Nuzzo, M. Frassi, A. Lojacono, T. Avcin, P.L. Meroni, A. Tincani

  189-194

  https://doi.org/10.4081/reumatismo.2010.189

  1125

  PDF: 673

• CO:11:5 | Laboratory preliminary results from an open label, prospective, phase ii descriptive pilot trial of belimumab therapy for refractory and/or non criteria manifestations of antiphospholipid syndrome Alice Barinotti¹, Massimo Radin¹, Irene Cecchi¹, Beatrice Ala¹, Chiara Raymondi¹, Elena Rubini¹, Silvia G. Foddai¹, Lois Ira Maniulit Capulong¹, Alessio Conti¹, Alessandro Morotti¹, Dario Roccatello¹, Roberta Fenoglio¹, Savino Sciascia¹. | ¹Università di Torino, Italy.

  Società Italiana di Reumatologia

  26-11-2025

  https://doi.org/10.4081/reumatismo.2025.1997

  78

• Primary antiphosholipid syndrome and hyperomocysteinemia: a study of a group of 29 patients

  T. Del Ross, A. Ruffatti, M. Tonello, G. Salmistraro, A. Calligaro, M. Favaro, M. Ciprian, S. Todesco

  283-287

  https://doi.org/10.4081/reumatismo.2006.283

  1018

  PDF: 1128
• 

  Adrenal hemorrhage and non-ST elevation myocardial infarction: an antiphospholipid syndrome dilemma

  G. El Hasbani, M. Del Pilar Morel, B. Tandoh, J.F. Vargas, R. Crusio

  18-09-2023

  https://doi.org/10.4081/reumatismo.2023.1584

  1342

  PDF: 799

• PO:15:221 | Proteins upregulated in thrombotic antiphospholipid syndrome link to platelet function in contrast with non-antiphospholipid-related thrombosis: insights from two systematic reviews Silvia Mancuso¹, Claudia Ciancarella¹, Luca Rapino¹, Simona Truglia¹, Cristiano Alessandri¹, Fabrizio Conti¹. | ¹Dipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari - Rheumatology Unit, Sapienza Univers, Roma, Italy.

  Società Italiana di Reumatologia

  26-11-2025

  https://doi.org/10.4081/reumatismo.2025.2041

  95

• Role of anti-prothrombin in antiphospholipid syndrome

  M. Cinquini, M. Vianelli, F. Allegri, R. Cattaneo, G. Balestrieri, A. Tincani

  243-250

  https://doi.org/10.4081/reumatismo.2002.243

  874

  PDF: 1367

• Confirmation of antiphospholipid antibody positivity: a year’s results in a cohort of 113 patients

  S. Cuffaro, T. Del Ross, M. Tonello, A. Bontadi, S. Olivieri, E. Salvan, A. Ruffatti, L. Punzi

  51-59

  https://doi.org/10.4081/reumatismo.2010.51

  1498

  PDF: 796

• Laboratory diagnosis of antiphospholipid syndrome

  V. Pengo, A. Ruffatti

  187-191

  https://doi.org/10.4081/reumatismo.2007.187

  850

  PDF: 845
• 

  The history of antiphospholipid syndrome

  A. Tincani, G. Fontana, C. Mackworth-Young

  21-03-2023

  https://doi.org/10.4081/reumatismo.2022.1556

  2839

  PDF: 2523

• PO:10:149 | Efficacy of anifrolumab in a case of systemic lupus erythematosus with pulmonary involvement Fabio Brandolino¹, Giulia Pazzola¹, Luca Ronzoni³, Andreina Teresa Manfredi^1|2, Carlo Salvarani^1|2 | ¹SC Reumatologia, IRCCS Arcispedale Santa Maria Nuova, AUSL Reggio Emilia; ²Università di Modena e Reggio Emilia, Scuola di specializzazione in Reumatologia, Modena; ³SC Malattie dell'Apparato Respiratorio, IRCCS Arcispedale Santa Maria Nuova, AUSL Reggio Emilia, Italy

  Società Italiana di Reumatologia

  26-11-2025

  https://doi.org/10.4081/reumatismo.2025.2146

  108
• 

  Biclonal gammopathy of undetermined significance in a patient with systemic lupus erythematosus and antiphospholipid syndrome

  V. Bruzzese, P. Scolieri, J. Pepe

  07-02-2022

  https://doi.org/10.4081/reumatismo.2021.1431

  5850

  PDF: 734

• CO:11:2 | Systemic lupus erythematosus with major neuropsychiatric involvement treated with anifrolumab: literature review and a case report Giulia Rizzo¹, Fabio Congiu¹, Elisabetta Chessa², Marta Paola Pireddu¹, Elena Ragusa¹, Alessandra Oliva¹, Marianna Salis¹, Alberto Cauli^1|2, Matteo Piga^1|2 | ¹SC Reumatologia, Dipartimento di Scienze Mediche e Salute Pubblica, Università di Cagliari Italy; ²SC Reumatologia, AOU Cagliari Italy

  Società Italiana di Reumatologia

  26-11-2025

  https://doi.org/10.4081/reumatismo.2025.2120

  117

• CO:11:4 | Unveiling frailty in active systemic lupus erythematosus  in the modern era of rheumatology: first real-life use of the SLICC-FI  in a cohort diagnosed after 2000 Angela Elia¹, Dina Zucchi², Michele Moretti¹, Elena Elefante², Chiara Cardelli¹, Linda Carli², Viola Signorini², Chiara Stagnaro², Chiara Tani¹, Marta Mosca¹. | ¹U.O. di Reumatologia, Dipartimento di Medicina Clinica e Sperimentale, Università di Pisa; ²U.O Reumatologia, Azienza Ospedaliero Universitaria Pisana, Pisa, Italy

  Società Italiana di Reumatologia

  26-11-2025

  https://doi.org/10.4081/reumatismo.2025.1996

  87

• PO:14:205 | Primary antiphospholipid antibody syndrome: association between new classification criteria manifestations and a higher-risk disease phenotype Sara Ferrigno¹, Vittorio Forte², Marco Panetta¹, Sergio Lisena¹, Giorgia Ranucci², Luigi De Marco¹, Elisabetta Greco¹, Alberto Bergamini¹, Maria Sole Chimenti¹, Paola Conigliaro¹. | ¹Rheumatology, allergology and clinical immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy; ²Hematology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.

  Società Italiana di Reumatologia

  26-11-2025

  https://doi.org/10.4081/reumatismo.2025.2034

  81